These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 21205125)

  • 1. Pharmaceutical interventions for obesity: a public health perspective.
    Caveney E; Caveney BJ; Somaratne R; Turner JR; Gourgiotis L
    Diabetes Obes Metab; 2011 Jun; 13(6):490-7. PubMed ID: 21205125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-obesity drugs: use, mechanisms and clinical importance.
    Adam O; Forth W
    Int J Clin Pharmacol Ther; 2001 Jun; 39(6):232-8. PubMed ID: 11430630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medical strategies for weight loss in the overweight and obese patient.
    Di Caro S; Hamad GG; Fernstrom MH; Schauer PR; Bonanomi G
    Minerva Gastroenterol Dietol; 2006 Dec; 52(4):415-30. PubMed ID: 17108871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Health economics of weight management: evidence and cost.
    Kouris-Blazos A; Wahlqvist ML
    Asia Pac J Clin Nutr; 2007; 16 Suppl 1():329-38. PubMed ID: 17392129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use and costs of bariatric surgery and prescription weight-loss medications.
    Encinosa WE; Bernard DM; Steiner CA; Chen CC
    Health Aff (Millwood); 2005; 24(4):1039-46. PubMed ID: 16012144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Economic evaluation of weight loss interventions in overweight and obese women.
    Roux L; Kuntz KM; Donaldson C; Goldie SJ
    Obesity (Silver Spring); 2006 Jun; 14(6):1093-106. PubMed ID: 16861615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of obesity as a chronic disease: nonpharmacologic, pharmacologic, and surgical options.
    Fujioka K
    Obes Res; 2002 Dec; 10 Suppl 2():116S-123S. PubMed ID: 12490660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increasing prevalence of obesity and clustered cardiometabolic risk: can treatment of the underlying cause reverse the trends?
    Ballantyne CM
    Crit Pathw Cardiol; 2007 Jun; 6(2):41-5. PubMed ID: 17667863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacotherapy for the obese patient.
    Dickerson LM; Carek PJ
    Prim Care; 2009 Jun; 36(2):407-15. PubMed ID: 19501251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medical interventions in adolescent obesity.
    Khan UI; Collier M
    Adolesc Med State Art Rev; 2008 Dec; 19(3):406-20, viii. PubMed ID: 19227383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The new role of pharmacotherapy for weight reduction in obesity.
    Fernstrom MH; Fernstrom JD
    Int J Clin Pract; 2002 Nov; 56(9):683-6. PubMed ID: 12469983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The global impact of noncommunicable diseases: estimates and projections.
    Manton KG
    World Health Stat Q; 1988; 41(3-4):255-66. PubMed ID: 3232413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological treatment of obesity in children and adolescents: current status and perspectives.
    Catoira N; Nagel M; Di Girolamo G; Gonzalez CD
    Expert Opin Pharmacother; 2010 Dec; 11(18):2973-83. PubMed ID: 20958104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-obesity drugs: status quo and recent advances.
    Zhu HJ; Jin ZM
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2011 Jun; 33(3):243-7. PubMed ID: 21718603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Weight reduction. Antiobesity drug treatment in type-2 diabetics].
    Verspohl EJ
    Pharm Unserer Zeit; 2002; 31(3):300-7. PubMed ID: 12071127
    [No Abstract]   [Full Text] [Related]  

  • 16. New antiobesity agents in type 2 diabetes: overview of clinical trials with sibutramine and orlistat.
    Scheen AJ; Ernest P
    Diabetes Metab; 2002 Dec; 28(6 Pt 1):437-45. PubMed ID: 12522323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacotherapy of obesity.
    Linné Y; Rössner S
    Clin Dermatol; 2004; 22(4):319-24. PubMed ID: 15475233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An update on the pharmacological treatment of obesity.
    Schnee DM; Zaiken K; McCloskey WW
    Curr Med Res Opin; 2006 Aug; 22(8):1463-74. PubMed ID: 16870072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological therapies for obesity.
    Kaplan LM
    Gastroenterol Clin North Am; 2005 Mar; 34(1):91-104. PubMed ID: 15823441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of response to sibutramine therapy in obese non-diabetic and diabetic patients.
    Finer N; Ryan DH; Renz CL; Hewkin AC
    Diabetes Obes Metab; 2006 Mar; 8(2):206-13. PubMed ID: 16448525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.